# Efficacy of Dihydroartemisinin for Treating PCOS

> **NCT06417099** · PHASE2 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 30 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Dihydroartemisinin

## Key facts

- **NCT ID:** NCT06417099
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-24
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06417099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06417099, "Efficacy of Dihydroartemisinin for Treating PCOS". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06417099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*